Dimensional Fund Advisors LP Stoke Therapeutics, Inc. Transaction History

Dimensional Fund Advisors LP

$405 Billion
Q4 2024

A detailed history of Dimensional Fund Advisors LP transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 538,900 shares of STOK stock, worth $4.23 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

538,900

Previous 265,010 103.35%

Holding current value

$4.23 Million

Previous $3.26 Million 82.56%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$10.8 - $13.92 $2.96 Million - $3.81 Million	273,890 Added 103.35%	538,900 $5.94 Million
Q3 2024 Nov 07, 2024	BUY	$12.24 - $15.92 $901,476 - $1.17 Million	73,650 Added 38.49%	265,010 $3.26 Million
Q2 2024 Aug 09, 2024	SELL	$11.03 - $17.52 $313,307 - $497,655	-28,405 Reduced 12.93%	191,360 $2.59 Million
Q1 2024 May 10, 2024	BUY	$4.12 - $14.17 $18,420 - $63,354	4,471 Added 2.08%	219,765 $2.97 Million
Q4 2023 Feb 07, 2024	SELL	$3.37 - $5.4 $145,341 - $232,891	-43,128 Reduced 16.69%	215,294 $1.13 Million
Q3 2023 Nov 09, 2023	SELL	$3.78 - $11.99 $308,912 - $979,858	-81,723 Reduced 24.03%	258,422 $1.02 Million
Q2 2023 Aug 09, 2023	BUY	$7.93 - $13.82 $368,848 - $642,809	46,513 Added 15.84%	340,145 $3.62 Million
Q1 2023 May 12, 2023	BUY	$7.65 - $10.38 $12,431 - $16,867	1,625 Added 0.56%	293,632 $2.45 Million
Q4 2022 Feb 09, 2023	SELL	$7.07 - $15.69 $332,212 - $737,257	-46,989 Reduced 13.86%	292,007 $2.7 Million
Q3 2022 Nov 10, 2022	BUY	$12.56 - $22.53 $929,126 - $1.67 Million	73,975 Added 27.91%	338,996 $4.35 Million
Q2 2022 Aug 12, 2022	BUY	$10.36 - $23.93 $1.17 Million - $2.71 Million	113,361 Added 74.75%	265,021 $3.5 Million
Q1 2022 May 13, 2022	BUY	$17.19 - $26.1 $1.37 Million - $2.08 Million	79,518 Added 110.22%	151,660 $3.19 Million
Q4 2021 Feb 09, 2022	BUY	$18.11 - $30.72 $496,630 - $842,434	27,423 Added 61.32%	72,142 $1.73 Million
Q3 2021 Nov 12, 2021	SELL	$23.65 - $34.44 $1.43 Million - $2.09 Million	-60,664 Reduced 57.57%	44,719 $1.14 Million
Q2 2021 Aug 12, 2021	SELL	$30.53 - $41.09 $105,023 - $141,349	-3,440 Reduced 3.16%	105,383 $3.55 Million
Q1 2021 May 14, 2021	BUY	$36.08 - $69.81 $2.49 Million - $4.82 Million	69,010 Added 173.34%	108,823 $4.22 Million
Q4 2020 Feb 25, 2021	BUY	$33.62 - $61.93 $1.34 Million - $2.47 Million	39,813 New	39,813 $2.47 Million

Others Institutions Holding STOK

# of Institutions

136

Shares Held

57.3M

Call Options Held

5.7K

Put Options Held

24.4K

View Full List

About Stoke Therapeutics, Inc.

Ticker STOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,419,300
Market Cap $309M
Description
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...

More about STOK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Stoke Therapeutics, Inc. Transaction History